Psychiatry and Neurology, Neurology · Cleveland, OH
NPI
1013369446
Since 2016
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
9500 Euclid Ave
Cleveland, OH, 44195
Phone (216) 444-2200
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
308 services
Medicare patients, 2024
164
Average age 65
Drug cost, 2024
$2.2M
1,875 prescriptions
Company payments, 2025
$19K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Claude Steriade was code 99214 (office e&m - established), 90 times for 56 patients. In total Claude Steriade billed 308 services in 21 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 90 | 56 | $97.43 | $8,769 |
| 95720 Neurologic | Facility | 69 | 49 | $179.47 | $12K |
| 99215 Office E&M - Established | Office | 44 | 28 | $150.92 | $6,641 |
| 95718 Neurologic | Facility | 13 | 13 | $117.20 | $1,524 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 13 | 13 | $14.45 | $188 |
By year: 2022 $54K for 408 services; 2023 $46K for 355 services; 2024 $35K for 308 services.
Medicare prescription drug claims, 2024
In 2024, the drug Claude Steriade prescribed most often to Medicare patients was Levetiracetam, with 168 prescriptions and refills. In total Claude Steriade wrote 1,875 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 168 | 336 | 29 | $5,890 |
| Xcopri Cenobamate | 125 | 161 | 13 | $243K |
| Lacosamide Generic | 116 | 146 | 13 | $11K |
| Clobazam Generic | 96 | 138 | 17 | $12K |
| Lamotrigine Generic | 92 | 138 | 13 | $1,016 |
| Vimpat Lacosamide | 72 | 77 | Under 11 | $74K |
| Lamotrigine Er Lamotrigine | 62 | 155 | 13 | $15K |
| Clonazepam Generic | 49 | 51 | 12 | $597 |
| Epidiolex Cannabidiol (Cbd) | 48 | 51 | Under 11 | $202K |
| Topiramate Generic | 45 | 93 | Under 11 | $612 |
| Divalproex Sodium Er Divalproex Sodium | 42 | 64 | Under 11 | $4,361 |
| Lamictal Lamotrigine | 40 | 48 | Under 11 | $35K |
| Zonisamide Generic | 40 | 108 | Under 11 | $2,130 |
| Fintepla Fenfluramine Hcl | 38 | 38 | Under 11 | $686K |
| Briviact Brivaracetam | 37 | 41 | Under 11 | $74K |
Brand drugs: 665 claims; generic drugs: 1,180 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Claude Steriade $19K ($19K in general payments such as food, travel and fees) from 7 companies. The largest payer was Neurelis, Inc. with $14K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.